GnRH microspheres- Goserelin Depot Injection 1 M

Goserelin (LHRH) is used for the treatment of hormone dependent tumors such as prostate cancer, advanced breast cancer and endometriosis.

SPARC’s Goserelin depot 1 M injection uses this proprietary biodegradable depot injection platform. Unlike the existing and marketed product where a thick implant is placed under the skin using a thick, blunt needle, our product is given as a conventional injection using normal needles.

Clinical trials have been initiated for the once-a-month product, and the once-in-three month product is at an advanced stage of development.